1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.
2Liu G,Zhou W,Christiani DC. Molecular epidemiology of non-small cell lung cancer [J]. Semin Respir Crit Care Med, 2005,26 (3) : 265 -272.
3Fasching PA,Gayther S,Pearce L,et al. Role of genetic polymorphisms and ovarian cancer susceptibility [J]. Mol On- col, 2009,3(2) : 171-181.
4Wang H,Zhang K,Qin H,et al. Genetic association be- tween angiotensinogen polymorphisms and lung cancer risk [J]. Medicine(Baltimore) ,2015,94(37) :e1250.
5Wen L,Jiang K,Yuan W,et al. Contribution of variants in CHRNA5/A3/B4 gene cluster on chromosome 15 to tobac-co smoking:from genetic association to mechanism [J]. Mol Neurobiol, 2016,53 ( 1 ) : 472-484.
6Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015,65:87-108.
7Siegel RL, Miller KD,Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015,65 ( 1 ) : 5-29.
8Ohki R,Nemoto J,Murasawa H,et al. Reprimo,a new can- didate mediator of the p53- mediated cell cycle arrest at the G2 phase [J]. Biol Chem, 2000,275 (30) : 22627-22630.
9Liu LH,Yang XE Implication of Reprimo and hMLH 1 gene methylation in early diagnosis of gastric carcinoma [J]. Int J Clin Exp Pathol, 2015,8 ( 11 ) : 14977-14982.
10Kurt B,Carmen I,Ismael R. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line [J]. Biol Res, 2016,49 ( 1 ) : 5.
